Omnicell Inc (OMCL) — 分析摘要
Omnicell Inc（OMCL）的市值为1.51十亿美元，最近一年的营收同比增长了+6.5%。净利润率为0.2%。当前市盈率为38.6倍。
核心要点
- 营收同比变化+6.5%
- 净利润率0.2%
- 市盈率38.6倍
与ELECTRONIC COMPUTERS板块的其他公司相比，OMCL的营收增长为+6.5%，市盈率为38.6倍。
Omnicell Inc (OMCL)
更新 — ET · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示无重大红旗
基于最新财报，没有触发重大的信用、利润率或趋势红旗。
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
行业
ELECTRONIC COMPUTERS
员工人数
3,485
总部
FORT WORTH, TX
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。